Claudia Janoschka

No current affiliations available for this person. The person is no longer active at the university.

Publications

Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response. Teschner VE; Fleck AK; Walter C; Schwarze AS; Eschborn M; Wirth T; Steinberg OV; Schulte-Mecklenbeck A; Lu IN; Herrera-Rivero M; Janoschka C; Lünemann JD; Schwab N; Meyer Zu Hörste G; Varghese J; Gross CC; Pul R; Kleinschnitz C; Mader S; Meinl E; Stoll M; Wiendl H; Klotz L (2023) In: Therapeutic Advances in Neurological Disorders, 16. doi:10.1177/17562864231211077 Research article (journal) \| Peer reviewed \| Published
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity Fleck AK, Hucke S, Teipel F, Eschborn M, Janoschka C, Liebmann M, Wami H, Korn L, Pickert G, Hartwig M, Wirth T, Herold M, Koch K, Falk-Paulsen M, Dobrindt U, Kovac S, Gross CC, Rosenstiel P, Trautmann M, Wiendl H, Schuppan D, Kuhlmann T, Klotz L (2021) In: Brain, 144(4), 1152-1166. doi:10.1093/brain/awab040 Research article (journal) \| Peer reviewed \| Published
Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis Herich S, Schneider-Hohendorf T, Rohlmann A, Khaleghi Ghadiri M, Schulte-Mecklenbeck A, Zondler L, Janoschka C, Ostkamp P, Richter J, Breuer J, Dimitrov S, Rammensee H, Grauer OM, Klotz L, Gross CC, Stummer W, Missler M, Zarbock A, Vestweber D, Wiendl H, Schwab N (2019) In: Brain, 142(11), 3411-3427. doi:10.1093/brain/awz301 Research article (journal) \| Peer reviewed \| Published
Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Populations into the Cerebrospinal Fluid-Results from the ToFingo Successor Study Lohmann L, Janoschka C, Schulte-Mecklenbeck A, Klinsing S, Kirstein L, Hanning U, Wirth T, Schneider-Hohendorf T, Schwab N, Gross CC, Eveslage M, Meuth SG, Wiendl H, Klotz L (2018) In: Frontiers in immunology, 9. doi:10.3389/fimmu.2018.01560 Research article (journal) \| Peer reviewed \| Published
Long-term natalizumab treatment enhances the pathogenic signature of Th17 cells - potential implications for treatment cessation? Janoschka C, Schulte-Mecklenbeck A, Starost L, Schafflick D, Schneider-Hohendorf T, Hoerste GM, Gross CC, Schwab N, Kuhlmann T, Wiendl H, Klotz L (2018) In: Multiple Sclerosis, 24(2), 669-670. Research article (journal) \| Peer reviewed \| Published

Show all publications

Projects

KFO 342 - Z: Immune System variables in healthy subjects and during systemic inflammation

Duration: 01/10/2023 - 30/09/2026 | 2nd Funding period

Funded by: DFG - Clinical Research Unit

Type of project: Subproject in DFG-joint project hosted at University of Münster

Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response. Teschner VE; Fleck AK; Walter C; Schwarze AS; Eschborn M; Wirth T; Steinberg OV; Schulte-Mecklenbeck A; Lu IN; Herrera-Rivero M; Janoschka C; Lünemann JD; Schwab N; Meyer Zu Hörste G; Varghese J; Gross CC; Pul R; Kleinschnitz C; Mader S; Meinl E; Stoll M; Wiendl H; Klotz L (2023) In: Therapeutic Advances in Neurological Disorders, 16. doi:10.1177/17562864231211077 Research article (journal) \| Peer reviewed \| Published
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity Fleck AK, Hucke S, Teipel F, Eschborn M, Janoschka C, Liebmann M, Wami H, Korn L, Pickert G, Hartwig M, Wirth T, Herold M, Koch K, Falk-Paulsen M, Dobrindt U, Kovac S, Gross CC, Rosenstiel P, Trautmann M, Wiendl H, Schuppan D, Kuhlmann T, Klotz L (2021) In: Brain, 144(4), 1152-1166. doi:10.1093/brain/awab040 Research article (journal) \| Peer reviewed \| Published
Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis Herich S, Schneider-Hohendorf T, Rohlmann A, Khaleghi Ghadiri M, Schulte-Mecklenbeck A, Zondler L, Janoschka C, Ostkamp P, Richter J, Breuer J, Dimitrov S, Rammensee H, Grauer OM, Klotz L, Gross CC, Stummer W, Missler M, Zarbock A, Vestweber D, Wiendl H, Schwab N (2019) In: Brain, 142(11), 3411-3427. doi:10.1093/brain/awz301 Research article (journal) \| Peer reviewed \| Published
Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Populations into the Cerebrospinal Fluid-Results from the ToFingo Successor Study Lohmann L, Janoschka C, Schulte-Mecklenbeck A, Klinsing S, Kirstein L, Hanning U, Wirth T, Schneider-Hohendorf T, Schwab N, Gross CC, Eveslage M, Meuth SG, Wiendl H, Klotz L (2018) In: Frontiers in immunology, 9. doi:10.3389/fimmu.2018.01560 Research article (journal) \| Peer reviewed \| Published
Long-term natalizumab treatment enhances the pathogenic signature of Th17 cells - potential implications for treatment cessation? Janoschka C, Schulte-Mecklenbeck A, Starost L, Schafflick D, Schneider-Hohendorf T, Hoerste GM, Gross CC, Schwab N, Kuhlmann T, Wiendl H, Klotz L (2018) In: Multiple Sclerosis, 24(2), 669-670. Research article (journal) \| Peer reviewed \| Published

Claudia Janoschka

Publications

Projects

Contact

Top-Links